ITAB - Institute for Advanced Biomedical Technologies
11
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Effect of rTMS on Neurotrophines Levels in CUD
Role: lead
Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression
Role: lead
Italian Registry of Cardiovascular Magnetic Resonance on Congenital Anomalies of the Coronary Arteries (ITACA-Registry)
Role: lead
Diagnostic Performance of a New Method for the Echocardiographic Assessment of Coronary Arteries Abnormalities
Role: lead
Accelerated rTMS in Gambling Disorder: a Multicentric, Randomized, Sham-controlled Trial
Role: lead
Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder
Role: lead
Correlates of Left Ventricular Global Longitudinal Strain and Surgical Intervention on Myocardial Bridges
Role: lead
Effects of Physical Exercise on Cardio-vascular Efficiency and Quality of Life in Breast Cancer Survivors
Role: lead
Assessment of Right Ventricular Function in Advanced Heart Failure
Role: lead
Repetitive Transcranial Magnetic Stimulation in Gambling Disorder
Role: lead
Transcranial Magnetic Stimulation for Cocaine Addiction
Role: lead
All 11 trials loaded